SABIC, Linde Group Successfully Commercialize Linear Alpha Olefins


Nov 30, 2009

Saudi Basic Industries Corp. (SABIC) and German-based The Linde Group announced the first successful commercialization of Linear Alpha Olefins (LAO) using α-SABLIN technology developed jointly by SABIC and Linde.

Discussions began in 1998 between SABIC and Linde for the development of technologies and plant capacity to produce LAO. In July 2004 SABIC’s manufacturing affiliate Jubail United Petrochemical Co. (United) awarded the contract to Linde for engineering, procurement and construction of the 150,000-metric-tons-per-year plant at Jubail on the Gulf coast of Saudi Arabia.

“This first commercialization of LAOs at Jubail is very much in keeping with SABIC’s continuous search for innovative technologies that can be employed to bring new and better product solutions to the marketplace,” says Abdulrahman Al-Ubaid, SABIC’s vice-president of technology and innovation.

"The commercialization of this technology is a big success for SABIC and Linde by using this technology in new commercial solutions and applications in global markets. The α SABLIN process is the first and only commercially proven LAO technology which is available for licensing to third parties," says Markus Raab, managing director of Linde's engineering division.

The α SABLIN manufacturing process uses ethylene as a feedstock for a one-stage homogeneous reaction that produces a full range of high-purity LAOs.
LAOs have a large variety of applications, such as light-cut production of Butene-1, Hexene-1 and Octene-1 used in the growing polyethylene market. Medium cuts such as Decene-1, Dodecene-1 and Tetradecene-1 are used for synthetic oils, detergents and shampoos. Heavy cuts are used in lube oil additives, surfactants, oil field chemicals and wax product applications.


SABIC and The Linde Group are CP 50 companies. To view the profile pages, visit

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments